BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

497 related articles for article (PubMed ID: 16956949)

  • 1. Human immunodeficiency virus type 1 Vpr induces DNA replication stress in vitro and in vivo.
    Zimmerman ES; Sherman MP; Blackett JL; Neidleman JA; Kreis C; Mundt P; Williams SA; Warmerdam M; Kahn J; Hecht FM; Grant RM; de Noronha CM; Weyrich AS; Greene WC; Planelles V
    J Virol; 2006 Nov; 80(21):10407-18. PubMed ID: 16956949
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human immunodeficiency virus type 1 Vpr-mediated G2 arrest requires Rad17 and Hus1 and induces nuclear BRCA1 and gamma-H2AX focus formation.
    Zimmerman ES; Chen J; Andersen JL; Ardon O; Dehart JL; Blackett J; Choudhary SK; Camerini D; Nghiem P; Planelles V
    Mol Cell Biol; 2004 Nov; 24(21):9286-94. PubMed ID: 15485898
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIV-1 Vpr-induced apoptosis is cell cycle dependent and requires Bax but not ANT.
    Andersen JL; DeHart JL; Zimmerman ES; Ardon O; Kim B; Jacquot G; Benichou S; Planelles V
    PLoS Pathog; 2006 Dec; 2(12):e127. PubMed ID: 17140287
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of the ATR-mediated DNA damage response by the HIV-1 viral protein R.
    Roshal M; Kim B; Zhu Y; Nghiem P; Planelles V
    J Biol Chem; 2003 Jul; 278(28):25879-86. PubMed ID: 12738771
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of the ATR pathway by human immunodeficiency virus type 1 Vpr involves its direct binding to chromatin in vivo.
    Lai M; Zimmerman ES; Planelles V; Chen J
    J Virol; 2005 Dec; 79(24):15443-51. PubMed ID: 16306615
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vpr cytopathicity independent of G2/M cell cycle arrest in human immunodeficiency virus type 1-infected CD4+ T cells.
    Bolton DL; Lenardo MJ
    J Virol; 2007 Sep; 81(17):8878-90. PubMed ID: 17553871
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence for a cytopathogenicity determinant in HIV-1 Vpr.
    Somasundaran M; Sharkey M; Brichacek B; Luzuriaga K; Emerman M; Sullivan JL; Stevenson M
    Proc Natl Acad Sci U S A; 2002 Jul; 99(14):9503-8. PubMed ID: 12093916
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ATR and GADD45alpha mediate HIV-1 Vpr-induced apoptosis.
    Andersen JL; Zimmerman ES; DeHart JL; Murala S; Ardon O; Blackett J; Chen J; Planelles V
    Cell Death Differ; 2005 Apr; 12(4):326-34. PubMed ID: 15650754
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heat shock protein 70 protects cells from cell cycle arrest and apoptosis induced by human immunodeficiency virus type 1 viral protein R.
    Iordanskiy S; Zhao Y; Dubrovsky L; Iordanskaya T; Chen M; Liang D; Bukrinsky M
    J Virol; 2004 Sep; 78(18):9697-704. PubMed ID: 15331702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human immunodeficiency virus type 1 Vpr-dependent cell cycle arrest through a mitogen-activated protein kinase signal transduction pathway.
    Yoshizuka N; Yoshizuka-Chadani Y; Krishnan V; Zeichner SL
    J Virol; 2005 Sep; 79(17):11366-81. PubMed ID: 16103188
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of Vpr in HIV-1 disease progression is independent of its G2 arrest induction function.
    Lai M; Chen J
    Cell Cycle; 2006 Oct; 5(19):2275-80. PubMed ID: 16969134
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Formation of mobile chromatin-associated nuclear foci containing HIV-1 Vpr and VPRBP is critical for the induction of G2 cell cycle arrest.
    Belzile JP; Abrahamyan LG; Gérard FC; Rougeau N; Cohen EA
    PLoS Pathog; 2010 Sep; 6(9):e1001080. PubMed ID: 20824083
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIV-1 Vpr induces G2 cell cycle arrest in fission yeast associated with Rad24/14-3-3-dependent, Chk1/Cds1-independent Wee1 upregulation.
    Matsuda N; Tanaka H; Yamazaki S; Suzuki J; Tanaka K; Yamada T; Masuda M
    Microbes Infect; 2006 Oct; 8(12-13):2736-44. PubMed ID: 16968670
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nuclear localization of Vpr is crucial for the efficient replication of HIV-1 in primary CD4+ T cells.
    Iijima S; Nitahara-Kasahara Y; Kimata K; Zhong Zhuang W; Kamata M; Isogai M; Miwa M; Tsunetsugu-Yokota Y; Aida Y
    Virology; 2004 Oct; 327(2):249-61. PubMed ID: 15351213
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The ataxia telangiectasia-mutated and Rad3-related protein is dispensable for retroviral integration.
    Dehart JL; Andersen JL; Zimmerman ES; Ardon O; An DS; Blackett J; Kim B; Planelles V
    J Virol; 2005 Feb; 79(3):1389-96. PubMed ID: 15650165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human immunodeficiency virus type 1 Vpr is a positive regulator of viral transcription and infectivity in primary human macrophages.
    Subbramanian RA; Kessous-Elbaz A; Lodge R; Forget J; Yao XJ; Bergeron D; Cohen EA
    J Exp Med; 1998 Apr; 187(7):1103-11. PubMed ID: 9529326
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dual regulation of L-selectin (CD62L) by HIV-1: Enhanced expression by Vpr in contrast with cell-surface down-modulation by Nef and Vpu.
    Giuliani E; Vassena L; Galardi S; Michienzi A; Desimio MG; Doria M
    Virology; 2018 Oct; 523():121-128. PubMed ID: 30119013
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phenotype of HIV-1 lacking a functional nuclear localization signal in matrix protein of gag and Vpr is comparable to wild-type HIV-1 in primary macrophages.
    Kootstra NA; Schuitemaker H
    Virology; 1999 Jan; 253(2):170-80. PubMed ID: 9918876
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIV-1 Vpr triggers natural killer cell-mediated lysis of infected cells through activation of the ATR-mediated DNA damage response.
    Ward J; Davis Z; DeHart J; Zimmerman E; Bosque A; Brunetta E; Mavilio D; Planelles V; Barker E
    PLoS Pathog; 2009 Oct; 5(10):e1000613. PubMed ID: 19798433
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human immunodeficiency virus type 1-induced macrophage gene expression includes the p21 gene, a target for viral regulation.
    Vázquez N; Greenwell-Wild T; Marinos NJ; Swaim WD; Nares S; Ott DE; Schubert U; Henklein P; Orenstein JM; Sporn MB; Wahl SM
    J Virol; 2005 Apr; 79(7):4479-91. PubMed ID: 15767448
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.